CA2564120A1 - Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples - Google Patents
Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples Download PDFInfo
- Publication number
- CA2564120A1 CA2564120A1 CA002564120A CA2564120A CA2564120A1 CA 2564120 A1 CA2564120 A1 CA 2564120A1 CA 002564120 A CA002564120 A CA 002564120A CA 2564120 A CA2564120 A CA 2564120A CA 2564120 A1 CA2564120 A1 CA 2564120A1
- Authority
- CA
- Canada
- Prior art keywords
- release rate
- neutral lipid
- component
- lipid
- active compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2692302A CA2692302C (fr) | 1997-01-31 | 1998-01-29 | Procede servant a utiliser des lipides neutres afin de modifier la libe ation in vivo depuis des liposomes a vesicules multiples |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/792,566 | 1997-01-31 | ||
US08/792,566 US5891467A (en) | 1997-01-31 | 1997-01-31 | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
CA002277956A CA2277956C (fr) | 1997-01-31 | 1998-01-29 | Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002277956A Division CA2277956C (fr) | 1997-01-31 | 1998-01-29 | Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2692302A Division CA2692302C (fr) | 1997-01-31 | 1998-01-29 | Procede servant a utiliser des lipides neutres afin de modifier la libe ation in vivo depuis des liposomes a vesicules multiples |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2564120A1 true CA2564120A1 (fr) | 1998-08-06 |
CA2564120C CA2564120C (fr) | 2010-04-13 |
Family
ID=37480474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2564120A Expired - Lifetime CA2564120C (fr) | 1997-01-31 | 1998-01-29 | Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2564120C (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1189597A1 (fr) * | 1999-06-04 | 2002-03-27 | SkyePharma Inc. | Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes |
WO2013064837A1 (fr) * | 2011-11-03 | 2013-05-10 | Isis Innovation Limited | Multisomes: réseaux de gouttelettes encapsulées |
EP2813220A3 (fr) * | 2010-04-09 | 2015-06-17 | Pacira Pharmaceuticals, Inc. | Procédé de formulation de vésicules membranaires synthétiques de grand diamètre |
US9831010B2 (en) | 2012-10-25 | 2017-11-28 | Oxford University Innovation Limited | Hydrogel network |
US10950376B2 (en) | 2012-10-25 | 2021-03-16 | Oxford University Innovation Limited | Droplet assembly method |
US11213797B2 (en) | 2012-12-07 | 2022-01-04 | Oxford University Innovation Limited | Droplet assembly by 3D printing |
US11998642B2 (en) | 2011-11-03 | 2024-06-04 | Oxford University Innovation Limited | Multisomes: encapsulated droplet networks |
-
1998
- 1998-01-29 CA CA2564120A patent/CA2564120C/fr not_active Expired - Lifetime
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003501376A (ja) * | 1999-06-04 | 2003-01-14 | スカイファーマ インコーポレーテッド | 疎水性薬物の持続性放出のための油コア組成物 |
EP1189597A4 (fr) * | 1999-06-04 | 2008-06-18 | Pacira Pharmaceuticals Inc | Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes |
EP1189597A1 (fr) * | 1999-06-04 | 2002-03-27 | SkyePharma Inc. | Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes |
US10045941B2 (en) | 2010-04-09 | 2018-08-14 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US10398648B2 (en) | 2010-04-09 | 2019-09-03 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
EP2813220A3 (fr) * | 2010-04-09 | 2015-06-17 | Pacira Pharmaceuticals, Inc. | Procédé de formulation de vésicules membranaires synthétiques de grand diamètre |
US9724302B2 (en) | 2010-04-09 | 2017-08-08 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US9730892B2 (en) | 2010-04-09 | 2017-08-15 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US9737482B2 (en) | 2010-04-09 | 2017-08-22 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US9737483B2 (en) | 2010-04-09 | 2017-08-22 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US9757336B2 (en) | 2010-04-09 | 2017-09-12 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
US9808424B2 (en) | 2010-04-09 | 2017-11-07 | Pacira Pharmaceuticals, Inc. | Method for formulating large diameter synthetic membrane vesicles |
AU2012330894B2 (en) * | 2011-11-03 | 2017-07-13 | Oxford University Innovation Limited | Multisomes: encapsulated droplet networks |
WO2013064837A1 (fr) * | 2011-11-03 | 2013-05-10 | Isis Innovation Limited | Multisomes: réseaux de gouttelettes encapsulées |
US10548852B2 (en) | 2011-11-03 | 2020-02-04 | Oxford University Innovation Limited | Multisomes: encapsulated droplet networks |
US11406603B2 (en) | 2011-11-03 | 2022-08-09 | Oxford University Innovation Limited | Multisomes: encapsulated droplet networks |
US11998642B2 (en) | 2011-11-03 | 2024-06-04 | Oxford University Innovation Limited | Multisomes: encapsulated droplet networks |
US9831010B2 (en) | 2012-10-25 | 2017-11-28 | Oxford University Innovation Limited | Hydrogel network |
US10950376B2 (en) | 2012-10-25 | 2021-03-16 | Oxford University Innovation Limited | Droplet assembly method |
US10978218B2 (en) | 2012-10-25 | 2021-04-13 | Oxford University Innovation Limited | Hydrogel network |
US11213797B2 (en) | 2012-12-07 | 2022-01-04 | Oxford University Innovation Limited | Droplet assembly by 3D printing |
Also Published As
Publication number | Publication date |
---|---|
CA2564120C (fr) | 2010-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2529167T3 (es) | Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares | |
US5552155A (en) | Fusogenic lipsomes and methods for making and using same | |
Mantripragada | A lipid based depot (DepoFoam® technology) for sustained release drug delivery | |
CA2378438C (fr) | Preparation d'agents therapeutiques a encapsulation lipidique | |
US5316771A (en) | Method of amphiphatic drug loading in liposomes by ammonium ion gradient | |
Vora et al. | Proniosome based transdermal delivery of levonorgestrel for effective contraception | |
CA1261751A (fr) | Liposomes fusionnes et methode d'induction a l'acide pour la fusion de liposomes | |
FI92647C (fi) | Menetelmä mikrokapseleiden valmistamiseksi | |
US4877561A (en) | Method of producing liposome | |
EP1005326B1 (fr) | Procede de production de liposomes comportant un pourcentage accru de compose encapsule | |
US20110177130A1 (en) | Methods for preparation of lipid-encapsulated therapeutic agents | |
CA2376202A1 (fr) | Preparation et forme galenique comprenant un compose actif acido-labile | |
US20010006643A1 (en) | Method of loading preformed liposomes using ethanol | |
CA2245466A1 (fr) | Composition d'ester de stanol et production de celle-ci | |
WO1998019709A3 (fr) | Reactifs cationiques pour transfection | |
CA2106405A1 (fr) | Vesicules lipidiques porteuses de gaz et d'oxygene | |
WO1992002244A1 (fr) | Accumulation d'acides amines et de peptides dans des liposomes | |
CA2187748C (fr) | Liposomes de fusion, leurs procedes de preparation et d'utilisation | |
CA2564120A1 (fr) | Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples | |
AU6374596A (en) | Biologically active composition comprising cyclosporine | |
CA2305533A1 (fr) | Vesicules de coalescence multilamellaires (mlcv) contenant des composes biologiquement actifs | |
AU698915B2 (en) | Ketoprofen liposomes | |
AU8298682A (en) | Slow absorption salicylic acid preparation | |
ES2086802T3 (es) | Formulaciones liposomicas de principios activos y procedimiento para su preparacion. | |
CA2346016C (fr) | Liposome paucilamellaire a glucosides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20180129 |